| __timestamp | Lantheus Holdings, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 301600000 | 4060800000 |
| Thursday, January 1, 2015 | 293461000 | 4603900000 |
| Friday, January 1, 2016 | 301853000 | 5280600000 |
| Sunday, January 1, 2017 | 331378000 | 4946200000 |
| Monday, January 1, 2018 | 343374000 | 4731700000 |
| Tuesday, January 1, 2019 | 347337000 | 4837400000 |
| Wednesday, January 1, 2020 | 339410000 | 5063300000 |
| Friday, January 1, 2021 | 425208000 | 4138700000 |
| Saturday, January 1, 2022 | 935061000 | 4451600000 |
| Sunday, January 1, 2023 | 1296429000 | 4655600000 |
Cracking the code
In the competitive landscape of the healthcare sector, Lantheus Holdings, Inc. and Perrigo Company plc have carved distinct paths over the past decade. From 2014 to 2023, Perrigo consistently outperformed Lantheus in terms of revenue, maintaining a robust average annual revenue of approximately $4.68 billion. In contrast, Lantheus, while starting at a modest $301 million in 2014, demonstrated impressive growth, culminating in a 330% increase to $1.3 billion by 2023.
This period saw Perrigo's revenue fluctuate slightly, peaking in 2016 and stabilizing around $4.65 billion in 2023. Meanwhile, Lantheus's strategic initiatives and market expansions fueled its revenue surge, particularly noticeable from 2021 onwards. This narrative of growth and stability highlights the diverse strategies employed by these companies in navigating the ever-evolving healthcare market.
Comparing Revenue Performance: Merck & Co., Inc. or Lantheus Holdings, Inc.?
Revenue Insights: AstraZeneca PLC and Perrigo Company plc Performance Compared
Who Generates More Revenue? Novartis AG or Lantheus Holdings, Inc.
Comparing Revenue Performance: Teva Pharmaceutical Industries Limited or Perrigo Company plc?
Bio-Techne Corporation and Lantheus Holdings, Inc.: A Comprehensive Revenue Analysis
Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Lantheus Holdings, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Who Generates More Revenue? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Perrigo Company plc
Revenue Showdown: Perrigo Company plc vs Merus N.V.
Breaking Down Revenue Trends: Perrigo Company plc vs Evotec SE
Perrigo Company plc vs MiMedx Group, Inc.: Examining Key Revenue Metrics